The Food and Drug Administration announced Thursday, February 17 that it is investigating certain powdered infant formula following four customer reports of children contracting serious infections stemming from the bacterium Cronobacter sakazakii and the strain Salmonella Newport have been linked to powdered infant formula produced in Abbott Nutrition’s Sturgis, Michigan, facility. As a result of the ongoing investigation, along with the U.S. Centers for Disease Control and Prevention (CDC) and state and local partners, the FDA is alerting consumers to avoid purchasing or using certain powdered infant formula products produced at this facility. This is an ongoing investigation, and the firm is working with the FDA to initiate a voluntary recall of the potentially affected product.
1. Submit a voluntary report via the Med Watch Voluntary Report @ https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm
2. Check their inventory for code below
3. Contain product for possible testing
The FDA is advising consumers not to use Similac, Alimentum, or EleCare powdered infant formulas if:
The FDA is investigating complaints of four infant illnesses from three states. All four cases related to these complaints were hospitalized and Cronobacter may have contributed to a death in one case. The FDA has initiated an onsite inspection at the facility. Findings to date include several positive Cronobacter sakazakii results from environmental samples taken by the FDA and adverse inspectional observations by the FDA investigators. A review of the firm’s internal records also indicate environmental contamination with Cronobacter sakazakii and the firm’s destruction of product due to the presence of Cronobacter.
“As this is a product used as the sole source of nutrition for many of our nation’s newborns and infants, the FDA is deeply concerned about these reports of bacterial infections,” said Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response. “We want to reassure the public that we’re working diligently with our partners to investigate complaints related to these products, which we recognize include infant formula produced at this facility, while we work to resolve this safety concern as quickly as possible.”
Additional Information:
The FDA is continuing to investigate and will provide additional consumer safety information when it becomes available.
2022-02-18T14:53:50-05:00